Company / Operating Cash Flow per Share
Arbutus Biopharma Corp Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.21
FY2025
5-year range
-$0.75 / -$0.21
FY2021-FY2025
Trend
+45.3%
vs FY2024
Sector context
#83 of 212
Health Care
What the data says
At $-0.21, Arbutus Biopharma Corp's operating cash flow per share ranks #83 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.22 in FY2019 to $-0.21 in FY2025.
Based on SEC 10-K filings.
-0.21 in FY2025.
Improved from $-0.55 to $-0.21 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#83 of 212 in Health CareTop 39% of 212This company -$0.21 Sector average -$14.72
▼
+98.6% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 45.3% year-over-year.
- Ranks #83 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.21 | +45.3% |
| FY2024 | -$0.38 | +30.1% |
| FY2023 | -$0.55 | -123.8% |
| FY2022 | -$0.24 | +67.6% |
| FY2021 | -$0.75 | +31.3% |
| FY2020 | -$1.10 | +10.3% |
| FY2019 | -$1.22 | -38.4% |
| FY2018 | -$0.88 | -0.0% |
| FY2017 | -$0.88 | +16.3% |
| FY2016 | -$1.06 | -2.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026